MTNB icon

Matinas BioPharma
MTNB

Overview Fund Trends Analyst Outlook Journalist POV

37 hedge funds and large institutions have $16.6M invested in Matinas BioPharma in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.25M
2
+$126K
3
+$116K
4
WG
Winton Group
United Kingdom
+$110K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$77.1K

Top Sellers

1
-$5.84M
2
-$657K
3
-$573K
4
Millennium Management
Millennium Management
New York
-$115K
5
TI
Telemetry Investments
New York
-$90.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$11K
27
$10K
28
$10K
29
$7K
30
$6K
31
$6K
32
$6K
33
$3K
34
$2K
35
$1K
36
$17
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3